Elizabeth Bhatt's most recent trade in eFFECTOR Therapeutics Inc was a trade of 800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
eFFECTOR Therapeutics Inc | Elizabeth P. Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
eFFECTOR Therapeutics Inc | Bhatt Elizabeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 2,000 | 2,000 | - | - | Stock Option (Right to Buy) | |
eFFECTOR Therapeutics Inc | Elizabeth Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
eFFECTOR Therapeutics Inc | Elizabeth Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
eFFECTOR Therapeutics Inc | Elizabeth Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 80,500 | 80,500 | - | - | Stock Option (Right to Buy) | |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 17,250 | 48,750 | - | 0 | Common Stock | |
eFFECTOR Therapeutics Inc | Elizabeth Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
eFFECTOR Therapeutics Inc | Elizabeth Bhatt | Director | 25 Aug 2021 | 9,047 | 9,047 | - | 0 | Class A Common Stock | ||
eFFECTOR Therapeutics Inc | Elizabeth Bhatt | Director | 25 Aug 2021 | 9,047 | 0 | - | - | Class B Common Stock | ||
eFFECTOR Therapeutics Inc | Elizabeth Bhatt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Aug 2021 | 8,453 | 8,453 | - | - | Class B Common Stock | |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2021 | 9,000 | 292,632 | - | - | Stock Option (Right to Buy) | |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. | 21 Jul 2021 | 9,000 | 9,000 | - | 4.6 | 41,490 | Common Stock |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Sale of securities on an exchange or to another person at price $ 36.41 per share. | 21 Jul 2021 | 6,640 | 2,360 | - | 36.4 | 241,762 | Common Stock |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Sale of securities on an exchange or to another person at price $ 37.43 per share. | 21 Jul 2021 | 2,360 | 0 | - | 37.4 | 88,335 | Common Stock |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. | 21 Apr 2021 | 9,000 | 9,000 | - | 4.6 | 41,490 | Common Stock |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 9,000 | 301,632 | - | - | Stock Option (Right to Buy) | |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Sale of securities on an exchange or to another person at price $ 40.38 per share. | 21 Apr 2021 | 5,417 | 2,612 | - | 40.4 | 218,749 | Common Stock |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Sale of securities on an exchange or to another person at price $ 41.21 per share. | 21 Apr 2021 | 2,612 | 0 | - | 41.2 | 107,649 | Common Stock |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Sale of securities on an exchange or to another person at price $ 39.30 per share. | 21 Apr 2021 | 971 | 8,029 | - | 39.3 | 38,160 | Common Stock |
Applied Molecular Transpor... | Elizabeth Bhatt | Chief Bus. & Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) |